The active comparator, new user study design in pharmacoepidemiology: historical foundations and contemporary application.

Constructing Inverse Probability Weights for Marginal Structural Models

Cole, S. R., & Hernan, M. A. (2008) · American Journal of Epidemiology · doi:10.1093/aje/kwn164 · Cited by 2,796

Marginal Structural Models to Estimate the Causal Effect of Zidovudine on the Survival of HIV-Positive Men

Hernán, M. Á., Brumback, B., & Robins, J. M. (2000) · Epidemiology · doi:10.1097/00001648-200009000-00012 · Cited by 1,772

Evaluating medication effects outside of clinical trials: new-user designs

Ray, W. A. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwg231 · Cited by 1,646

A meta-analysis of the association between adherence to drug therapy and mortality

Simpson, S. H., Eurich, D. T., Majumdar, S. R., Padwal, R. S., Tsuyuki, R. T., Varney, J., & Johnson, J. A. (2006) · BMJ · doi:10.1136/bmj.38875.675486.55 · Cited by 1,353

Research Methods in Occupational Epidemiology

Checkoway, H., Pearce, N. E., & Kriebel, D. (2004) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195092424.001.0001 · Cited by 889

Standardized Mortality Ratios and the "Healthy Worker Effect": Scratching Beneath the Surface

McMichael, A. J. (1976) · Journal of Occupational and Environmental Medicine · doi:10.1097/00043764-197603000-00009 · Cited by 770

Effectiveness of Influenza Vaccine in the Community-Dwelling Elderly

Nichol, K. L., Nordin, J. D., Nelson, D. B., Mullooly, J. P., & Hak, E. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa070844 · Cited by 647

The Evolving Concept of the Healthy Worker Survivor Effect

Arrighi, H. M., & Hertz‐Picciotto, I. (1994) · Epidemiology · doi:10.1097/00001648-199403000-00009 · Cited by 553

Evidence of bias in estimates of influenza vaccine effectiveness in seniors

Jackson, L. A., Jackson, M. L., Nelson, J. C., Neuzil, K. M., & Weiss, N. S. (2005) · International Journal of Epidemiology · doi:10.1093/ije/dyi274 · Cited by 490

Confounding Control in Healthcare Database Research

Brookhart, M. A., Stürmer‎, T., Glynn, R. J., Rassen, J. A., & Schneeweiß, S. (2010) · Medical Care · doi:10.1097/mlr.0b013e3181dbebe3 · Cited by 391

Causal Inference Methods in Pharmacoepidemiology

Pazzagli, L., & Li, X. (2021) · Springer eBooks · doi:10.1007/978-3-319-56015-1_14-2

Evaluating benefits and harms of deprescribing using routinely collected data

Moriarty, F., Thompson, W., & Boland, F. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91888-6.00036-3

Thromboembolic Events in Users of Warfarin Treated with Different Skeletal Muscle Relaxants

Leonard, C. E., Brensinger, C. M., Bilker, W. B., Soprano, S. E., Dhopeshwarkar, N., Hecht, T. E. H., Kasner, S. E., Nutescu, E. A., Holbrook, A. M., Carr, M., et al. (2022) · Medicina · doi:10.3390/medicina58091171

Causal Inference Methods in Pharmacoepidemiology

Pazzagli, L., & Li, X. (2022) · Springer eBooks · doi:10.1007/978-3-030-62059-2_14

Analysis of the Improved Conventional Dynamic Comparator and the Edge-Pursuit Comparator

Zhou, Y. (2022) · Highlights in Science Engineering and Technology · doi:10.54097/hset.v27i.3782

Methodology of the brodalumab assessment of hazards: a multicentre observational safety (BRAHMS) study

Reilev, M., Jensen, P. B., Ranch, L. S., Egeberg, A., Furu, K., Gembert, K., Hägg, D., Haug, U., Karlstad, Ø., Reutfors, J., et al. (2023) · BMJ Open · doi:10.1136/bmjopen-2022-066057

Critique of “Angiotensin‐converting enzyme inhibitors reduce community‐acquired pneumonia hospitalization and mortality”

Her, Q. L., Dhopeshwarkar, N., & Feeney, T. (2023) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2773

Reply to: Comparator choices in pharmacoepidemiology studies of Alzheimer’s disease

Zhang, P., Hou, Y., Chiang, C., Pieper, A. A., Cummings, J. L., & Cheng, F. (2023) · Nature Aging · doi:10.1038/s43587-023-00418-w

Cardiovascular Outcomes of Alpha-Blockers Versus 5-Alpha Reductase Inhibitors Among Patients with Benign Prostatic HyperplasiaPreprint

Zhang, J., Latour, C. D., Olawore, O., Pate, V., Friedlander, D. F., Stürmer‎, T., Funk, M. J., & Jensen, B. C. (2023) · medRxiv · doi:10.1101/2023.09.16.23295658

Evaluating the comparability of osteoporosis treatments using propensity score and negative control outcome methods in UK and Denmark electronic health record databasesPreprint

Rathod‐Mistry, T., Tan, E. H., Strauss, V. Y., O’Kelly, J., Giorgianni, F., Baxter, R., Brunetti, V. C., Pedersen, A. B., Ehrenstein, V., & Prieto‐Alhambra, D. (2023) · medRxiv · doi:10.1101/2023.10.02.23296212

Mendelian randomization revealing the protective effect of sodium-glucose cotransporter 2 inhibition on prostate cancer with verified evidence from electronic healthcare and biological dataPreprint

Zheng, J., Lu, J., Qi, J., Yang, Q., Zhao, H., Liu, H., Ye, Y., Xu, M., Xu, Y., Wang, T., et al. (2023) · medRxiv · doi:10.1101/2023.10.10.23296790

Optimal P2Y12 inhibitor durations in older men and older women following an acute myocardial infarction: A nationwide cohort study using Medicare data

Hickson, R. P., Kucharska‐Newton, A., Rodgers, J. E., Sleath, B. L., & Fang, G. (2023) · American Heart Journal Plus Cardiology Research and Practice · doi:10.1016/j.ahjo.2023.100339

Lower risk of dementia with Lewy bodies among users of glycolysis enhancing drugs in a new user, active comparator designPreprint

Hart, A. A., Aldridge, G. M., Zhang, Q., Narayanan, N. S., & Simmering, J. E. (2023) · medRxiv · doi:10.1101/2023.12.05.23299455

Reply to: Comment on: Association of sulfonylureas with the risk of dementia: A population‐based cohort study

Wu, C., & Swardfager, W. (2024) · Journal of the American Geriatrics Society · doi:10.1111/jgs.18769

Association between Class of Antihypertensive Drugs and Risk of Incident Dementia: A Multinational Population-Based Cohort StudyPreprint

Cheung, E. C. L., Adesuyan, M., Szilcz, M., Ellett, L. M. K., Shah, S. H., Jani, Y. H., Hägg, S., Pratt, N. L., Lau, K. K., Luo, H., et al. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4796032

Modern Epidemiological Study Designs

Kass, P. H. (2024) · Springer eBooks · doi:10.1007/978-1-4614-6625-3_8-1

The impact of different strategies for modeling associations between medications at low doses and health outcomes: a simulation study and practical application to postpartum opioid use

Spieker, A. J., Adgent, M. A., Osmundson, S. S., Phillips, S. E., Mitchel, E. F., Leech, A. A., Grijalva, C. G., & Wiese, A. D. (2024) · American Journal of Epidemiology · doi:10.1093/aje/kwae147

Phosphodiesterase-5 Inhibitors and Dementia Risk: Confounding by Indication in Real-World Studies

Wu, C., & Swardfager, W. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-240520

Use of fluoroquinolones and risk of rhegmatogenous retinal detachment: a retrospective cohort study using two nationwide representative claims databases

Lin, T., Wang, J., Wang, G. H., Huang, Y.-Y., Chen, M.-C., Dong, Y., & Lo-Ciganic, W.-H. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1414221

Pharmacoepidemiology in Cardiovascular Research

Ko, D., Yoo, T. K., & Kim, D. H. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15734-9.00031-5

Comparative effectiveness of olodaterol/tiotropium and vilanterol/umeclidinium among COPD patients: a high-dimensional propensity score matched new user cohort study in a US medicare population

Shah, C. H., Reed, R. M., Wastila, L. J., Onukwugha, E., Gopalakrishnan, M., & Zafarí, Z. (2024) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2024.2446598

[Artículo traducido] Evidencias de la vida real para uso regulatorio: El ejemplo de DARWIN EU®

Raventós, B., & Prieto‐Alhambra, D. (2025) · Farmacia Hospitalaria · doi:10.1016/j.farma.2025.03.012

Critical appraisal of “Impact of human papillomavirus 9-valent vaccine on viral clearance after surgical treatment: A single-center retrospective observational study”

Mueed, A., & Amjad, F. (2025) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2025.114013

The Effect of Opioid Agonist Treatment on Injection-Related Sequelae: A Population-Based Observational Study

Lim, J., Bruneau, J., Platt, R. W., & Panagiotoglou, D. (2025) · Drug Safety · doi:10.1007/s40264-025-01574-1

Pregnancy and ADHD Medications: Is It Time for Clinical Guidelines?

Dreier, J. W., & Madsen, K. B. (2025) · Paediatric and Perinatal Epidemiology · doi:10.1111/ppe.70048

Toward a causal understanding of sedative-hypnotic use on suicide risk: methodological considerations, challenges, and future directions for real-world data studies

Bertisch, S. M., & Wong, J. (2025) · SLEEP · doi:10.1093/sleep/zsaf195

Association of hormone therapy with cardiovascular events in females using statins for prevention

Lukey, A., Stuart, G. C. E., Kaur, P., & Hanley, G. E. (2025) · Climacteric · doi:10.1080/13697137.2025.2524171

Quantifying selection bias due to unobserved patients in pharmacoepidemiologic studies of severe COVID-19 cohortsPreprint

Bokern, M., Rentsch, C. T., Quint, J. K., Schultze, A., & Douglas, I. (2025) · medRxiv · doi:10.1101/2025.07.24.25332123

Letter to the Editor

CROMER, S. J., Alkabbani, W., & Patorno, E. (2025) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000003653

Depression risk of 5-alpha reductase inhibitors: A systematic review and meta-analysis with a focus on comparator groupsPreprint

Nguyen, M. T., Tran, T. H., & Donovan, J. (2025) · medRxiv · doi:10.1101/2025.08.21.25333991

Angiotensin receptor-neprilysin inhibitors and mortality among patients with HFrEF.

Svanström, H., Mkoma, G., Hviid, A., & Pasternak, B. (2025) · American Journal of Cardiology · doi:10.1016/j.amjcard.2025.08.063

KIDNEY INJURY DURING TREATMENT WITH AFLIBERCEPT VERSUS RANIBIZUMAB

Bell, C. M., El-Defrawy, S. R., Gill, S. S., Shellenberger, J. P., Whitehead, M., Bell, C. M., Bronskill, S. E., Paterson, J. M., & McIsaac, M. A. (2025) · Retina · doi:10.1097/iae.0000000000004653

Glucagon-like Peptide 1 Receptor Agonists and Risk of Pulmonary HypertensionPreprint

Garry, J. D., Kundu, S., Alcorn, C., Eden, S., Smith, E. K., Greevy, R. A., Tindle, H. A., Freiberg, M. S., & Brittain, E. L. (2025) · medRxiv · doi:10.1101/2025.09.18.25336100

Association Discovery Approach in Healthcare Big Data to Identify Drug Safety and Drug Repurposing Signals

Tan, G. S. Q., Miller, L., Wade, S., Ilomäki, J., Lukose, D., Rong, J., & Webb, G. I. (2025) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.70080

Potential Bias in Self‐Controlled Case Series Design: Impact of Incident Versus Prevalent Scenarios of Exposure and Outcome

Jung, K., Byun, S. J., Lim, G., Lee, J., Lee, H., Kim, J. H., & Shin, J. (2025) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.70234

Comparing IPCW Models to Adjust for Informative Censoring During COVID ‐19 Using Data From the Clinical Practice Research Datalink

Aubrac, G., Webster‐Clark, M., & Platt, R. W. (2025) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.70235

Invited commentary: building rigorous clinical evidence for drug–drug interactions

Tassopoulou, P., & Douros, A. (2025) · American Journal of Epidemiology · doi:10.1093/aje/kwaf222

Initiation of sodium‐glucose cotransporter‐2 inhibitors and the risk of infection‐related hospitalisations: A population‐based cohort study

Arvez, M. J. A., Tan, G. S. Q., Ademi, Z., Ilomäki, J., & Bell, J. S. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70279

A disproportionality analysis on proprotein convertase subtilisin/kexin type 9 inhibitors and hypersensitivity and anaphylaxis

Dermiki‐Gkana, F., Gravel, C. A., Kontogiorgis, C. A., & Douros, A. (2025) · Scientific Reports · doi:10.1038/s41598-025-24945-1

Real-World Effectiveness: Addressing Selection Bias in the Well Elderly 2 Study Strengthens Effect Estimates

Jeon, P., Pritchard, K. T., Yoo, E., & Hong, I. (2025) · OTJR Occupational Therapy Journal of Research · doi:10.1177/15394492251388012

Evaluation of potential approaches for counting person-time in instances where no active comparator is present

Giorgio, K., Lutsey, P. L., Wang, W., Walker, R. F., Norby, F. L., & Huling, J. D. (2025) · American Journal of Epidemiology · doi:10.1093/aje/kwaf266

Cardio-renal outcomes in type 2 diabetes patients with advanced chronic kidney disease on SGLT2 inhibitors or GLP-1 receptor agonists

Chen, J., Tsai, M., Ho, W.-Y., Fang, Y.-W., Chen, M., & Hsiao, C.-C. (2025) · The American Journal of Medicine · doi:10.1016/j.amjmed.2025.12.011

Additional file 4 of The risk of all-cause and cause-specific mortality in people prescribed mirtazapine: an active comparator cohort study using electronic health records

Joseph, R. M., Jack, R. H., Morriss, R. K., Knaggs, R. D., Butler, D., Hollis, C., Hippisley‐Cox, J., & Coupland, C. (2022) · Figshare · doi:10.6084/m9.figshare.19106069

Additional file 1 of The risk of all-cause and cause-specific mortality in people prescribed mirtazapine: an active comparator cohort study using electronic health records

Joseph, R. M., Jack, R. H., Morriss, R. K., Knaggs, R. D., Butler, D., Hollis, C., Hippisley‐Cox, J., & Coupland, C. (2022) · Figshare · doi:10.6084/m9.figshare.19106051

Additional file 2 of The risk of all-cause and cause-specific mortality in people prescribed mirtazapine: an active comparator cohort study using electronic health records

Joseph, R. M., Jack, R. H., Morriss, R. K., Knaggs, R. D., Butler, D., Hollis, C., Hippisley‐Cox, J., & Coupland, C. (2022) · Figshare · doi:10.6084/m9.figshare.19106057

Additional file 2 of Low continuation of antipsychotic therapy in Parkinson disease – intolerance, ineffectiveness, or inertia?

Pham Nguyen, T. P., Abraham, D. S., Thibault, D. P., Weintraub, D., & Willis, A. W. (2021) · Figshare · doi:10.6084/m9.figshare.14843361

Additional file 3 of The risk of all-cause and cause-specific mortality in people prescribed mirtazapine: an active comparator cohort study using electronic health records

Joseph, R. M., Jack, R. H., Morriss, R. K., Knaggs, R. D., Butler, D., Hollis, C., Hippisley‐Cox, J., & Coupland, C. (2022) · Figshare · doi:10.6084/m9.figshare.19106063

Additional file 1 of Low continuation of antipsychotic therapy in Parkinson disease – intolerance, ineffectiveness, or inertia?

Pham Nguyen, T. P., Abraham, D. S., Thibault, D. P., Weintraub, D., & Willis, A. W. (2021) · Figshare · doi:10.6084/m9.figshare.14843358

Additional file 7 of The risk of all-cause and cause-specific mortality in people prescribed mirtazapine: an active comparator cohort study using electronic health records

Joseph, R. M., Jack, R. H., Morriss, R. K., Knaggs, R. D., Butler, D., Hollis, C., Hippisley‐Cox, J., & Coupland, C. (2022) · Figshare · doi:10.6084/m9.figshare.19106084

Additional file 5 of The risk of all-cause and cause-specific mortality in people prescribed mirtazapine: an active comparator cohort study using electronic health records

Joseph, R. M., Jack, R. H., Morriss, R. K., Knaggs, R. D., Butler, D., Hollis, C., Hippisley‐Cox, J., & Coupland, C. (2022) · Figshare · doi:10.6084/m9.figshare.19106075

Additional file 6 of The risk of all-cause and cause-specific mortality in people prescribed mirtazapine: an active comparator cohort study using electronic health records

Joseph, R. M., Jack, R. H., Morriss, R. K., Knaggs, R. D., Butler, D., Hollis, C., Hippisley‐Cox, J., & Coupland, C. (2022) · Figshare · doi:10.6084/m9.figshare.19106078

Additional file 1 of Association of education attainment, smoking status, and alcohol use disorder with dementia risk in older adults: a longitudinal observational study

Tang, H., Shaaban, C. E., DeKosky, S. T., Smith, G. E., Hu, X., Jaffee, M. S., Salloum, R. G., Bian, J., & Guo, J. (2024) · Figshare · doi:10.6084/m9.figshare.27059017

Additional file 1 of The association between prescription drugs and colorectal cancer prognosis: a nationwide cohort study using a medication-wide association study

Woo, H.-T., Jeong, S.-Y., & Shin, A. (2024) · Figshare · doi:10.6084/m9.figshare.26603329

Additional file 1 of Chronic kidney outcomes associated with GLP-1 receptor agonists versus long-acting insulins among type 2 diabetes patients requiring intensive glycemic control: a nationwide cohort study

Peng, Z.-Y., Yang, C.-T., Lin, W.-H., Yao, W.-Y., Ou, H.-T., & Kuo, S. (2024) · Figshare · doi:10.6084/m9.figshare.26623015

Additional file 8 of The risk of all-cause and cause-specific mortality in people prescribed mirtazapine: an active comparator cohort study using electronic health records

Joseph, R. M., Jack, R. H., Morriss, R. K., Knaggs, R. D., Butler, D., Hollis, C., Hippisley‐Cox, J., & Coupland, C. (2022) · Figshare · doi:10.6084/m9.figshare.19106090

The Impact of Low EHR-Continuity on Effect Estimates: Evidence from Two EHR-Medicare Linked Databases

Jin, Y., Tong, A., Wyss, R., Yang, J. C., & Lin, K. J. (2025) · Clinical Epidemiology · doi:10.2147/clep.s549772

Psychotropic deprescribing across different prescribing professions in New Mexico and Louisiana

Hughes, P. M., Niznik, J. D., McGrath, R. E., Tak, C. R., Christian, R. B., Sleath, B. L., & Thomas, K. C. (2025) · PLOS mental health. · doi:10.1371/journal.pmen.0000408

Association Between Sodium–Glucose Cotransporter‐2 Inhibitors and Sepsis Risk in Patients With Type 2 Diabetes Mellitus

Wu, C.-Y., Lai, C., Ho, C., Wu, Y.-C., Liao, K., Wang, J.-J., Wang, D.-C., & Liang, F. (2026) · Journal of Diabetes Research · doi:10.1155/jdr/1437417 · Cited by 1

Quantifying selection bias due to unobserved patients in pharmacoepidemiologic studies of severe COVID-19 cohorts

Bokern, M., Rentsch, C. T., Quint, J. K., Schultze, A., & Douglas, I. (2026) · BMC Medical Research Methodology · doi:10.1186/s12874-025-02732-w

COPD and vitamin K antagonism: a cohort study of 1-year all-cause mortality and risk of hospitalisation due to a severe exacerbation

Gundersen, B.-E. V., Vognsen, A. K., Eklöf, J. V., Sivapalan, P., Linneberg, A. R., Biering‐Sørensen, T., & Jensen, J. S. (2026) · BMJ Open Respiratory Research · doi:10.1136/bmjresp-2025-003814

CARDIOVASCULAR PHARMACOTHERAPY AND PERIODONTAL OUTCOMES: A NARRATIVE REVIEW

Șufaru, I.-G., Mârţu, I., Tatarciuc, D., Mârțu, M.-A., Mârţu, S., Solomon, S. M., & Păsărin, L. (2025) · Romanian Journal of Oral Rehabilitation · doi:10.62610/rjor.2025.4.17.1

Cardiovascular Outcomes with α1 Adrenergic Receptor Antagonists vs 5α-Reductase InhibitorsPreprint

Kirkland, L. G., Goyal, M., Kubinski, D. J., Zhuo, S., Li, Q., & Jensen, B. C. (2026) · medRxiv · doi:10.64898/2026.02.23.26346940

IL-6 Receptor Antagonists and Severe Post-COVID-19 Outcomes: An Emulated Target TrialPreprint

Butzin-Dozier, Z., Kumar, M. N., Ji, Y., Wang, L., Anzalone, A. J., Hurwitz, E. G., Patel, R. C., Wong, R., Bramante, C. T., & Sines, B. (2026) · medRxiv · doi:10.64898/2026.02.27.26347274

Reply

Khataniar, H., Vo, K., & Duong, N. K. (2026) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2026.02.022

Initiation of SGLT2 Inhibitors Versus DPP‐4 Inhibitors in Metformin Users and Risk of Incident Depression: A Nationwide, Claims‐Based Active‐Comparator New‐User Study

Park, S., Jeong, S., Kim, H. J., Lee, D. H., Choi, S. J., & Park, S. M. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.71261

Utilisation des bases de l'Assurance Maladie pour l'analyse de l'utilisation et de la sécurité des anticoagulants oraux dans la fibrillation auriculaire

Maura, G. (2018) · doi:10.70675/2f5c24c0z8e87z449bza0b2zedba3e80d8df

STRASS 2 target trial emulation: Bridging the gap between trial efficacy and real-world effectiveness

Talathi, R., Hubbard, R. A., Somasundar, P. S., Espat, N. J., & Kwon, S. (2026) · Surgery · doi:10.1016/j.surg.2026.110187

Utilisation des données de délivrances pharmaceutiques pour l’identification et la quantification des effets indésirables associées à la consommation des médicaments prescrits en milieu extrahospitalier

Vilcu, A. (2020) · theses.fr (ABES) · doi:10.70675/f9c139aez74c4z48c2zb9cfz3ac42cf9d257

Definitions, Principles, and Concepts of Pharmacoepidemiology and Pharmacovigilance

Chinzowu, T., & Nishtala, P. S. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-26472-6.00047-4

Comparative Effectiveness and Safety of Fluticasone-Umeclidinium-Vilanterol and Beclomethasone-Glycopyrronium-Formoterol Single-Inhaler Triple Therapies for COPD: Real-World Observational Study

Cherian, M., Dell’Aniello, S., & Suissa, S. (2026) · International Journal of COPD · doi:10.2147/copd.s585037

Target Trial Emulation for Non-Pharmaceutical Interventions: Methodological Challenges and Solutions

Wong, J. J., DiTosto, J. D., Chakraborti, Y., Hinkle, S. N., Mumford, S. L., Schisterman, E. F., & Caniglia, E. C. (2026) · Current Epidemiology Reports · doi:10.1007/s40471-026-00384-y

Proton Pump Inhibitors Versus H2 Blockers and the Risk of Incident Dementia in Adults Younger Than 65

Azinge, N., Elkomi, R., Bisrat, M., Gillani, S. F., Deverapalli, M., Beyene, E., Michael, M. B., & Deonarine, A. (2026) · Cureus · doi:10.7759/cureus.109101

Resources and applications of public biomedical data

Liu, M., Ye, Z., Liu, H., Ma, P., Pang, H., Li, Y., Wang, Q., Shen, Y., Xie, X., & Zhao, Y. (2026) · Frontiers in Bioinformatics · doi:10.3389/fbinf.2026.1782956

Comparing Care Coordination and Food Assistance Referrals to Improve Diabetes Outcomes: A Cohort Study

Berkowitz, S. A., Dankovchik, J., Kuhn, M. L., Ochoa, A. M., LaPoint, M., Gao, M., Basu, S., Hudgens, M. G., Byhoff, E., & Gold, R. B. (2026) · Journal of General Internal Medicine · doi:10.1007/s11606-026-10550-z

Comparative effectiveness of antidepressant augmentation regimens in children and adolescents with major depressive disorder

Lee, H., Castillo, W. C., Rose, R. A., Reeves, G. M., Qato, D. M., & dosReis, S. (2026) · Journal of Affective Disorders · doi:10.1016/j.jad.2026.122057

Comparative Effectiveness and Safety of Once-Weekly Injectable Semaglutide Versus Dulaglutide in Individuals with Type 2 Diabetes Managed in UK Primary Care: A Population-Based Cohort Study

Ulrich, F. S., Nielsen, M. F., Napoli, N., & Burden, A. M. (2026) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2026.101738

Association of GLP1-Receptor Agonists With Risk of Hematologic Malignancies in People With Diabetes

García, S. R., Zaw, S., Carilli, A., & Mansi, I. A. (2026) · Clinical Lymphoma Myeloma & Leukemia · doi:10.1016/j.clml.2026.06.007

Mortality in Castration Resistant Prostate Cancer Patients With and Without Pre‐Existing Cardiovascular Disease Receiving Oral Androgen Receptor Pathway Inhibitors

Asiri, I. M., Chen, R. C., Master, V. A., Mi, L., James, S. E., Moore, C., Bryce, A. H., Tilburt, J. C., Riaz, I. B., Naqvi, S. A. A., et al. (2026) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.70405

The association between sodium-glucose cotransporter 2 inhibitor and risk of pancreatic cancer among patients with type 2 diabetes mellitus: A real-world cohort study

Tu, Y.-K., Liang, Y.-C., Wu, Y.-J., Hung, K.-C., Yu, T., Lai, C., Chen, C.-C., & Wu, J. (2026) · Medicine · doi:10.1097/md.0000000000049365

Low-dose lithium vs valproate and incident dementia diagnoses in older adults: A propensity-matched cohort study using electronic health record data

da Silva, A. M. P., Santos, D. H., Júnior, D. V. D. S. L., Cardoso, L. J. C., Perry, G., & Kishi, T. (2026) · Psychiatry Research · doi:10.1016/j.psychres.2026.117300

Risk of perioperative cardiorespiratory complications and mortality associated with preoperative glucagon-like peptide-1 receptor agonist use in type 2 diabetes mellitus. Comment on Br J Anaesth 2026; 136: 86–97

Ciardi, F. (2026) · British Journal of Anaesthesia · doi:10.1016/j.bja.2026.04.069

Comment on: Exploring the effects of GLP-1 receptor agonists in fibromyalgia: a propensity-matched real-world cohort using the TriNetX research platform

Ciaffi, J., Caporali, R., & Ursini, F. (2026) · Lara D. Veeken · doi:10.1093/rheumatology/keag350

Glycolysis-enhancing α1-adrenergic antagonists have therapeutic potential in Alzheimer’s disease

Zhang, Q., Schultz, J. L., Simmering, J. E., Kirkpatrick, B. Q., Weber, M. A., Skuodas, S., Hicks, T., Pierce, G., Laughlin, M., George, B., et al. (2026) · Alzheimer s Research & Therapy · doi:10.1186/s13195-026-02135-z · Cited by 5

Long‐Term Cardiovascular Risks of Anticholinergic Versus Non‐Anticholinergic Antidepressants: A Target Trial Emulation With Negative Control Correction

Xu, Y., Xu, H., Guo, J., Her, Q. L., Li, R., Lai, Y., Zhang, Y., Tan, E. C. K., & Zhan, S. (2026) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.70434

Methodological considerations in pharmacoepidemiologic analyses of real-world data

CROMER, S. J., & Alkabbani, W. (2026) · Journal of Shoulder and Elbow Surgery · doi:10.1016/j.jse.2026.07.002

Semaglutide use linked to lower COVID-19 and influenza severity with better renal outcomes after pandemic or seasonal infection

Matson, R. P., Venkatakrishnan, A., Murugadoss, K., & Soundararajan, V. (2026) · Biology Methods and Protocols · doi:10.1093/biomethods/bpag042 · Cited by 1

P-glycoprotein inhibitory activity of angiotensin II receptor blockers and DOAC-related bleeding risk: Clinical implications and future directions

Akasaki, Y. (2026) · Hypertension Research · doi:10.1038/s41440-026-02733-2

Electronic health record–observed lithium persistence after within-service initiation in bipolar disorder: an incident-initiator cohort study from a multinational tertiary psychiatric service in the United Arab Emirates

Bokhari, S. A., Elnoor, M., Alnor, M. A., & Javaid, S. F. (2026) · International Journal of Bipolar Disorders · doi:10.1186/s40345-026-00434-w

GLP-1 receptor agonist initiation and risk of colorectal cancer and colonic polyps

Mari, A. A. M., Le, M. A., Rizvi, A., & Mansi, I. A. (2026) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2026.07.010

Sodium‐Glucose Cotransporter 2 Inhibitors and Cancer Risk in Patients With Type 2 Diabetes Mellitus: An Active Comparator, New‐User Cohort Study

Li, Y., Zeng, H., Du, F., Wu, L., Ke, X., Li, P., Song, Y., Zhao, H., & Wang, S. (2026) · International Journal of Cancer · doi:10.1002/ijc.70642

GLP-1–based incretin therapy is associated with lower incident Alzheimer’s disease and cardiorenal events in adults with documented neuropsychiatric, cognitive, or sensory risk

Murugadoss, K., Venkatakrishnan, A., & Soundararajan, V. (2026) · Biology Methods and Protocols · doi:10.1093/biomethods/bpag043

Bowel Obstruction/Ileus Associated With the Use of Glucagon‐Like Peptide‐1 Receptor Agonists: A Nationwide Database Study

Matsuo, Y., Okada, A., Sakamoto, T., & Yasunaga, H. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.71189

Association Between Herpes Zoster Vaccination and Dementia Risk: A Systematic Review and Meta-Analysis

Zhang, Q., Hu, Q., Yaming, W., Li, J., & Chen, S. (2026) · Vaccines · doi:10.3390/vaccines14080685

Comparative Effectiveness and Cardiovascular Safety of Romosozumab versus Teriparatide in Osteoporosis Patients with CKD

Hung, C., Yang, F., Huang, H.-E., & Wei, J. C. (2026) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.0000001168

Comparative risk of hepatocellular carcinoma and mortality among initiators of GLP-1 receptor agonists versus other glucose-lowering therapies: a target trial emulation

Hernández‐Pérez, J. G., Abdelgadir, O., Jang, S., Ernest, D. K., Zhang, X., Shah, D. P., Hong, A. S., Almandoz, J. P., Cowell, L. G., Messiah, S. E., et al. (2026) · Hepatology International · doi:10.1007/s12072-026-11138-9

Safety of Antiseizure Medications During Direct Oral Anticoagulant Therapy in Epilepsy

Schubert, K., Ferreira‐Atuesta, C., Soma, A., Zelano, J., Seiffge, D. J., Brigo, F., Trinka, E., Mishra, N. K., Russo, E., Lip, G. Y. H., et al. (2026) · JAMA Neurology · doi:10.1001/jamaneurol.2026.2712

Unequal follow-up, not two findings: comment on GLP-1 receptor agonists and ischemic optic neuropathy in patients with type 2 diabetes and obesity

Gahlot, A., Kavya, A., Sanku, N. K., Dhyani, A., & Srinivasan, H. (2026) · AJO International · doi:10.1016/j.ajoint.2026.100301

Initiation of ARB-Based vs ACEI-Based Antihypertensive Therapy on Dementia and Mortality Risk According to Blood-Brain Barrier Permeability

Andrews, R. M., Ofori-Atta, B. S., Xu, Y., Shi, J., Derington, C. G., Greene, T., Jacobs, J. A., Pruzin, J. J., Chhatwal, J. P., Cohen, J. B., et al. (2026) · Neurology Open Access · doi:10.1212/wn9.0000000000000133

Contrasting the impact of fluoroquinolone exposure on aortic aneurysm and dissection risk: Insights from a US multicenter database study

Chang, R., Chen, Y.-T., Wang, S., Chen, Y.-S., Hung, Y., & Wei, C.-C. (2026) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2026.08.004

Repurposing Denosumab for Knee Osteoarthritis: A Real‐World Signal That Now Needs a Trial

Wei, J. C., Sun, J.-S., Liu, K., & Huang, S.-W. (2026) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.70828

Core Concepts in Pharmacoepidemiology: New‐User Designs

Her, Q. L., Rouette, J., Young, J. C., Webster‐Clark, M., & Tazare, J. (2024) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.70048 · Cited by 39

Primary non‐adherence and the new‐user design

Li, X., Cole, S. R., Westreich, D. J., & Brookhart, M. A. (2018) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.4403 · Cited by 21

Invited Commentary: The Prevalent New-User Design in Pharmacoepidemiology—Challenges and Opportunities

Filion, K. B., & Yu, Y. (2020) · American Journal of Epidemiology · doi:10.1093/aje/kwaa284 · Cited by 6

New‐user and prevalent‐user designs and the definition of study time origin in pharmacoepidemiology: A review of reporting practices

Luijken, K., Spekreijse, J. J., van Smeden, M., Gardarsdóttir, H., & Groenwold, R. H. H. (2021) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.5258 · Cited by 31

New-user designs with conditional propensity scores: a unified complement to the traditional active comparator new-user approach

Gagne, J. J. (2017) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.4189 · Cited by 5